Skip to main content
John Orloff, MD, Endocrinology, Chester, NJ

John Jacob Orloff MD

Diabetes, Lipid Metabolism


Physician

Join to View Full Profile
  • 2 Fieldcrest RdChester, NJ 07930

  • Phone+1 862-778-3586

Dr. Orloff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 1984 - 1986
  • University of Vermont College of Medicine
    University of Vermont College of MedicineClass of 1983

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 1998 - 2017

Publications & Presentations

PubMed

Press Mentions

  • Caelum and Alexion Present Additional Phase 2 Data Reinforcing Safety and Tolerability of CAEL-101 in AL Amyloidosis at the European Hematology Association Congress 2021
    Caelum and Alexion Present Additional Phase 2 Data Reinforcing Safety and Tolerability of CAEL-101 in AL Amyloidosis at the European Hematology Association Congress 2021June 11th, 2021
  • Alexion Announces FDA Approval of ULTOMIRIS® (Ravulizumab-Cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Alexion Announces FDA Approval of ULTOMIRIS® (Ravulizumab-Cwvz) for Children and Adolescents with Paroxysmal Nocturnal Hemoglobinuria (PNH)June 7th, 2021
  • FDA Approves New Ultomiris Formulation That Shortens Infusion Time
    FDA Approves New Ultomiris Formulation That Shortens Infusion TimeOctober 14th, 2020
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: